{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:03Z","timestamp":1787237463885,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-020-0080-0","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T12:03:58Z","timestamp":1592827438000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing"],"prefix":"10.1038","volume":"1","author":[{"given":"Sara","family":"Parsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2782-8994","authenticated-orcid":false,"given":"Ana","family":"Ortega-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsia-Yuan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Teater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-5947","authenticated-orcid":false,"given":"Ed","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce P.","family":"Pasion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-9657","authenticated-orcid":false,"given":"Prathibha","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9699-0931","authenticated-orcid":false,"given":"Jeannie M.","family":"Camarillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-4765","authenticated-orcid":false,"given":"Paul M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garcia-Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-kyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil L.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Socci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-5256","authenticated-orcid":false,"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-8683","authenticated-orcid":false,"given":"Giovanni","family":"Ciriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-9472","authenticated-orcid":false,"given":"Michael R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-6274","authenticated-orcid":false,"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kivanc","family":"Birsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari M.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-4670","authenticated-orcid":false,"given":"Hans-Guido","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"80_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","volume":"15","author":"K Basso","year":"2015","unstructured":"Basso, K. & Dalla-Favera, R. Germinal centres and B cell lymphomagenesis. Nat. Rev. Immunol. 15, 172\u2013184 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"80_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrc.2017.127","volume":"18","author":"S Huet","year":"2018","unstructured":"Huet, S., Sujobert, P. & Salles, G. From genetics to the clinic: a translational perspective on follicular lymphoma. Nat. Rev. Cancer 18, 224\u2013239 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"80_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz, G. & Staudt, L. M. Aggressive lymphomas. N. Engl. J. Med. 362, 1417\u20131429 (2010).","journal-title":"N. Engl. J. Med."},{"key":"80_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130\u2013140 (2014).","journal-title":"Cell Rep."},{"key":"80_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/324158a0","volume":"324","author":"FG Haluska","year":"1986","unstructured":"Haluska, F. G., Finver, S., Tsujimoto, Y. & Croce, C. M. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V\u2013D\u2013J joining. Nature. 324, 158\u2013161 (1986).","journal-title":"Nature."},{"key":"80_CR6","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel, R., Sehn, L. H. & Gascoyne, R. D. Pathogenesis of follicular lymphoma. J. Clin. Invest. 122, 3424\u20133431 (2012).","journal-title":"J. Clin. Invest."},{"key":"80_CR7","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1073\/pnas.86.12.4589","volume":"86","author":"G Nunez","year":"1989","unstructured":"Nunez, G. et al. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc. Natl Acad. Sci. USA 86, 4589\u20134593 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"80_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3943","volume":"21","author":"A Ortega-Molina","year":"2015","unstructured":"Ortega-Molina, A. et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat. Med. 21, 1199\u20131208 (2015).","journal-title":"Nat. Med."},{"key":"80_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y. et al. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas. Cancer Discov. 7, 38\u201353 (2017).","journal-title":"Cancer Discov."},{"key":"80_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nm.3940","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat. Med. 21, 1190\u20131198 (2015).","journal-title":"Nat. Med."},{"key":"80_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/2159-8290.CD-16-1417","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma. Cancer Discov. 7, 322\u2013337 (2017).","journal-title":"Cancer Discov."},{"key":"80_CR12","doi-asserted-by":"publisher","first-page":"e1003137","DOI":"10.1371\/journal.pgen.1003137","volume":"9","author":"S De","year":"2013","unstructured":"De, S. et al. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet. 9, e1003137 (2013).","journal-title":"PLoS Genet."},{"key":"80_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.3413","volume":"47","author":"H Kretzmer","year":"2015","unstructured":"Kretzmer, H. et al. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. Nat. Genet. 47, 1316\u20131325 (2015).","journal-title":"Nat. Genet."},{"key":"80_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang, M. & Vousden, K. H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16, 650\u2013662 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"80_CR15","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","volume":"4","author":"J Ye","year":"2014","unstructured":"Ye, J. et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 4, 1406\u20131417 (2014).","journal-title":"Cancer Discov."},{"key":"80_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","volume":"153","author":"WG Kaelin Jr.","year":"2013","unstructured":"Kaelin, W. G. Jr. & McKnight, S. L. Influence of metabolism on epigenetics and disease. Cell 153, 56\u201369 (2013).","journal-title":"Cell"},{"key":"80_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2015.12.014","volume":"61","author":"ODK Maddocks","year":"2016","unstructured":"Maddocks, O. D. K., Labuschagne, C. F., Adams, P. D. & Vousden, K. H. Serine metabolism supports the methionine cycle and DNA\/RNA methylation through de novo ATP synthesis in cancer cells. Mol. Cell 61, 210\u2013221 (2016).","journal-title":"Mol. Cell"},{"key":"80_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature14363","volume":"520","author":"D Kim","year":"2015","unstructured":"Kim, D. et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520, 363\u2013367 (2015).","journal-title":"Nature"},{"key":"80_CR19","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1073\/pnas.1103623108","volume":"108","author":"DD Anderson","year":"2011","unstructured":"Anderson, D. D., Quintero, C. M. & Stover, P. J. Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria. Proc. Natl Acad. Sci. USA 108, 15163\u201315168 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"80_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature25460","volume":"554","author":"RJ Morscher","year":"2018","unstructured":"Morscher, R. J. et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature 554, 128\u2013132 (2018).","journal-title":"Nature"},{"key":"80_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2018.01.024","volume":"69","author":"DR Minton","year":"2018","unstructured":"Minton, D. R. et al. Serine catabolism by SHMT2 is required for proper mitochondrial translation initiation and maintenance of formylmethionyl-tRNAs. Mol. Cell 69, 610\u2013621.e5 (2018).","journal-title":"Mol. Cell"},{"key":"80_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature20132","volume":"539","author":"F Kottakis","year":"2016","unstructured":"Kottakis, F. et al. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis. Nature 539, 390\u2013395 (2016).","journal-title":"Nature"},{"key":"80_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"80_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1084\/jem.20132120","volume":"211","author":"E Oricchio","year":"2014","unstructured":"Oricchio, E. et al. Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J. Exp. Med. 211, 1379\u20131391 (2014).","journal-title":"J. Exp. Med."},{"key":"80_CR25","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","volume":"103","author":"A Egle","year":"2004","unstructured":"Egle, A., Harris, A. W., Bath, M. L., O\u2019Reilly, L. & Cory, S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103, 2276\u20132283 (2004).","journal-title":"Blood"},{"key":"80_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6","volume":"87","author":"A Pajic","year":"2000","unstructured":"Pajic, A. et al. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 87, 787\u2013793 (2000).","journal-title":"Int. J. Cancer"},{"key":"80_CR27","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.1706617114","volume":"114","author":"GS Ducker","year":"2017","unstructured":"Ducker, G. S. et al. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proc. Natl Acad. Sci. USA 114, 11404\u201311409 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"80_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding, J. et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 18, 896\u2013907 (2013).","journal-title":"Cell Metab."},{"key":"80_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1126\/science.1226603","volume":"339","author":"N Shyh-Chang","year":"2013","unstructured":"Shyh-Chang, N. et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339, 222\u2013226 (2013).","journal-title":"Science"},{"key":"80_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/leu.2013.270","volume":"28","author":"WS Stevenson","year":"2014","unstructured":"Stevenson, W. S. et al. DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. Leukemia 28, 787\u2013793 (2014).","journal-title":"Leukemia"},{"key":"80_CR31","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1038\/sj.onc.1207857","volume":"23","author":"Z Shan","year":"2004","unstructured":"Shan, Z., Parker, T. & Wiest, J. S. Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 23, 6612\u20136620 (2004).","journal-title":"Oncogene"},{"key":"80_CR32","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1002\/cncr.25279","volume":"116","author":"J La Rochelle","year":"2010","unstructured":"La Rochelle, J. et al. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma. Cancer 116, 4696\u20134702 (2010).","journal-title":"Cancer"},{"key":"80_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P. et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22, 547\u2013560 (2012).","journal-title":"Cancer Cell"},{"key":"80_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"80_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","volume":"3","author":"RA Cairns","year":"2013","unstructured":"Cairns, R. A. & Mak, T. W. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 3, 730\u2013741 (2013).","journal-title":"Cancer Discov."},{"key":"80_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304.e6 (2018).","journal-title":"Cell"},{"key":"80_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7744","volume":"6","author":"AK Witkiewicz","year":"2015","unstructured":"Witkiewicz, A. K. et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat. Commun. 6, 6744 (2015).","journal-title":"Nat. Commun."},{"key":"80_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 (2016).","journal-title":"Nat. Med."},{"key":"80_CR39","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1128\/MCB.22.16.5793-5800.2002","volume":"22","author":"MA Nikiforov","year":"2002","unstructured":"Nikiforov, M. A. et al. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22, 5793\u20135800 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"80_CR40","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1073\/pnas.0931346100","volume":"100","author":"TJ Haggerty","year":"2003","unstructured":"Haggerty, T. J., Zeller, K. I., Osthus, R. C., Wonsey, D. R. & Dang, C. V. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc. Natl Acad. Sci. USA 100, 5313\u20135318 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"80_CR41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/leu.2008.240","volume":"23","author":"SS Wang","year":"2009","unstructured":"Wang, S. S. et al. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia 23, 596\u2013602 (2009).","journal-title":"Leukemia"},{"key":"80_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"key":"80_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869\u2013874 (2011).","journal-title":"Nat. Genet."},{"key":"80_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller, M. et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst. 92, 564\u2013569 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"80_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A Merlo","year":"1995","unstructured":"Merlo, A. et al. 5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nat. Med. 1, 686\u2013692 (1995).","journal-title":"Nat. Med."},{"key":"80_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4904","volume":"5","author":"MR Green","year":"2014","unstructured":"Green, M. R. et al. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma. Nat. Commun. 5, 3904 (2014).","journal-title":"Nat. Commun."},{"key":"80_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500\u2013501 (2006).","journal-title":"Nat. Genet."},{"key":"80_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"H-G Wendel","year":"2004","unstructured":"Wendel, H.-G. et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332\u2013337 (2004).","journal-title":"Nature"},{"key":"80_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W B\u00e9guelin","year":"2013","unstructured":"B\u00e9guelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23, 677\u2013692 (2013).","journal-title":"Cancer Cell"},{"key":"80_CR50","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1101\/gad.1690808","volume":"22","author":"KJ Mavrakis","year":"2008","unstructured":"Mavrakis, K. J. et al. Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev. 22, 2178\u20132188 (2008).","journal-title":"Genes Dev."},{"key":"80_CR51","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.20181726","volume":"216","author":"K Singh","year":"2019","unstructured":"Singh, K. et al. c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma. J. Exp. Med. 216, 1509\u20131524 (2019).","journal-title":"J. Exp. Med."},{"key":"80_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"80_CR53","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nmeth.2722","volume":"10","author":"PG Engstr\u00f6m","year":"2013","unstructured":"Engstr\u00f6m, P. G. et al. Systematic evaluation of spliced alignment programs for RNA-seq data. Nat. Methods 10, 1185\u20131191 (2013).","journal-title":"Nat. Methods"},{"key":"80_CR54","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nprot.2007.106","volume":"2","author":"BA Garcia","year":"2007","unstructured":"Garcia, B. A. et al. Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat. Protoc. 2, 933\u2013938 (2007).","journal-title":"Nat. Protoc."},{"key":"80_CR55","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"80_CR56","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1007\/s13361-019-02255-x","volume":"30","author":"JM Camarillo","year":"2019","unstructured":"Camarillo, J. M. et al. Coupling fluorescence-activated cell sorting and targeted analysis of histone modification profiles in primary human leukocytes. J. Am. Soc. Mass Spectrom. 30, 2526\u20132534 (2019).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"80_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin, A. et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13, R87 (2012).","journal-title":"Genome Biol."},{"key":"80_CR58","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cell.2019.07.031","volume":"178","author":"VR Sanghvi","year":"2019","unstructured":"Sanghvi, V. R. et al. The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase. Cell 178, 807\u2013819.e21 (2019).","journal-title":"Cell"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-0080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-0080-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-0080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:41:51Z","timestamp":1670370111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-0080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1038\/s43018-020-0080-0","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D. has received personal consultancy fees from Roche, Corvus Pharmaceuticals, Physicians\u2019 Education Resource, Seattle Genetics, Takeda, EUSA Pharma and AbbVie, and research grants from Roche. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}